Papers we read closely — mostly immunology, oncology and cell therapy, with the method section treated as seriously as the conclusion.
Each entry states the journal, the group and the finding, then what it changes for someone running experiments.
A genome-wide in vivo CRISPR screen in colorectal cancer identifies DNMT3A as the top epigenetic driver. It acts twice: promoter methylation silences TNFRSF1A/B, and a non-enzymatic function opens cholesterol synthesis through NFYA, producing zymosterol that blocks SREBP2 processing. The CAR-T work in this paper used the Eynos RV02-20 retroviral vector at MOI 5.
English summaryNanjing Drum Tower Hospital (Sun Lingyun group): how microbial metabolites change mesenchymal stem-cell function and the therapeutic response in a lupus-like model.
English summaryNanjing Drum Tower Hospital (Sun Lingyun group): the interferon-α–HERC6 axis and what it implies for targeting type I interferon signalling.
English summaryJiangsu Provincial People's Hospital (Li Xiangcheng group): USP1 acts on two arms of lipid metabolism at once, and interrupting it restores immune visibility in cholangiocarcinoma.
English summaryRuijin Hospital team: combining single-cell transcriptomics with high-parameter flow cytometry to define pathogenic B-cell states that bulk profiling averages away.
English summaryZhongda Hospital, Southeast University: low-intensity ultrasound transiently opens the nasal barrier and enables co-delivery of a β-receptor agent, with the safety window characterised.
English summaryZhejiang University of Technology: γ-tocotrienol raises antigen visibility, turning a PD-1-resistant model into a responsive one.
English summaryTongji University: mechanical cues change exosome cargo and targeting, with consequences for how exosomes are produced for therapeutic use.
English summaryTongji University: mechanosensing through Piezo1 changes macrophage polarisation and amplifies downstream immune activation.
English summaryRuijin Hospital team: age-associated B cells expand in the pancreas and define a distinct inflammatory state in type 1 AIP.
English summaryNanjing University (Sun Lingyun group): SecTAC extends targeted degradation to extracellular proteins, widening the range of targets that can be removed rather than inhibited.
English summary11 articles in this section. Every article has an English page — each card opens it, with the same figures and the same caveats.
Tell us your cell type, sample source and downstream assay — we will suggest an isolation route, a culture condition and the matching catalogue numbers.